Medecision Sets IPO Terms

Medecision Inc., a Wayne, Pa.-based provider of medical management solutions to healthcare payers and regional health information organizations, has set its proposed IPO terms to 5.5 million common shares being offered at between $14 and $16 per share. It plans to trade on the Nasdaq under ticker symbol MEDE, with Cowen & Co. and Wachovia Securities serving as co-lead underwriters. Medecision has raised $38.4 million in VC funding from firms like Grotech Capital Group, Stockwell Fund, Liberty Ventures, DWS Investment and Britannia Business Expansion Fund.